PodParley PodParley
PodParley
Primary analysis of patients with high-risk localized, locally recurrent, or regionally advanced cutaneous squamous cell carcinoma treated with neoadjuvant PD-1 therapy - report from SITC 2025 episode artwork

EPISODE · Nov 27, 2025 · 5 MIN

Primary analysis of patients with high-risk localized, locally recurrent, or regionally advanced cutaneous squamous cell carcinoma treated with neoadjuvant PD-1 therapy - report from SITC 2025

from Medical Digest & Congress Report · host Medical Congress News

Professor Gino In presented data from the NeoPOWER trial, to study the role of neoadjuvant PD-1 alone in CSCC at SITC's 40th Anniversary Annual Meeting.Video: https://medicaldigest.org/scientific-contents/interview:primary-analysis-patients-high-risk-localized-locally-recurrent-or-regionally-advanced-cutaneous-squamous-cell-carcinoma-treated-neoadjuvant-pd-1-therapy

Episode metadata supplied by the publisher feed · Published Nov 27, 2025

Embed this episode

NOW PLAYING

Primary analysis of patients with high-risk localized, locally recurrent, or regionally advanced cutaneous squamous cell carcinoma treated with neoadjuvant PD-1 therapy - report from SITC 2025

0:00 5:09

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 5 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on November 27, 2025.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!